Related Experiment Video
Updated: Nov 8, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
The roles and regulation of MDM2 and MDMX: it is not just about p53
Alyssa M Klein1, Rafaela Muniz de Queiroz2, Divya Venkatesh2
1Integrated Program in Cellular, Molecular, and Biomedical Studies, Columbia University, New York, New York 10032, USA.
Abstract:
Most well studied as proteins that restrain the p53 tumor suppressor protein, MDM2 and MDMX have rich lives outside of their relationship to p53. There is much to learn about how these two proteins are regulated and how they can function in cells that lack p53. Regulation of MDM2 and MDMX, which takes place at the level of transcription, post-transcription, and protein modification, can be very intricate and is context-dependent. Equally complex are the myriad roles that these two proteins play in cells that lack wild-type p53; while many of these independent outcomes are consistent with oncogenic transformation, in some settings their functions could also be tumor suppressive. Since numerous small molecules that affect MDM2 and MDMX have been developed for therapeutic outcomes, most if not all designed to prevent their restraint of p53, it will be essential to understand how these diverse molecules might affect the p53-independent activities of MDM2 and MDMX.
Insights
MDM2 and MDMX proteins regulate more than just the p53 tumor suppressor. Their complex, context-dependent functions and regulation in p53-deficient cells are crucial for understanding cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Biology
- Protein Regulation
Background:
- MDM2 and MDMX are primarily known as inhibitors of the p53 tumor suppressor.
- Their roles and regulation extend beyond the p53 pathway, particularly in p53-deficient cells.
- Understanding these p53-independent functions is critical for comprehensive cancer research.
Purpose of the Study:
- To explore the intricate regulation of MDM2 and MDMX.
- To elucidate the diverse functions of MDM2 and MDMX in cells lacking functional p53.
- To assess the impact of therapeutic small molecules on p53-independent activities.
Main Methods:
- Analysis of transcriptional, post-transcriptional, and protein modification regulatory mechanisms.
- Investigation of MDM2 and MDMX functions in various cellular contexts, including p53-deficient models.
- Evaluation of small molecule effects on MDM2/MDMX activities.
Main Results:
- MDM2 and MDMX exhibit complex, context-dependent regulation.
- Their functions in p53-deficient cells can be oncogenic or tumor-suppressive.
- Therapeutic small molecules targeting MDM2/MDMX may have unintended effects on p53-independent functions.
Conclusions:
- MDM2 and MDMX possess significant p53-independent roles.
- Further research is needed to fully understand their regulation and functions in cancer.
- Knowledge of these p53-independent activities is essential for developing effective targeted therapies.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Master Transcription Regulators
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...

